What’s a total !@#$ show these stocks are been at a total loss for ages
Uross03
prije 6 mjeseci
Im in
In at 1.42
Wish me luck (if there’s any)!
Cl1f0
prije 6 mjeseci
VOLUME IS UP⬆️⬆️⬆️
Little spike and looking at the volume there will be another soon. No merger yet but I keep saying we only need to stay above $1 for another week and then we have a high percentage of merger talks thats when we see a rocket. But thats wont be the half of it any of these private companies are looking to merge. And let me tell you they are looking for a shell. Then this is a game changer. It does have to happen to be a game changer but QNCX has the best fit out of all the shells.
1. Xaira Therapeutics
Backing: Launched in April 2024 with $1 billion in committed funding from major firms like ARCH Venture Partners and Foresite Capital.
Why it fits: It is one of the only private biotechs to actually hit the $1 billion funding mark in a single launch. They focus on AI-driven drug discovery, a high-value sector that often attracts significant investor interest.
2. Kailera Therapeutics
Backing: Has raised approximately $1 billion in total private funding as of late 2025/early 2026, including a massive $600 million Series B.
Industry Focus: Obesity (GLP-1) and related metabolic diseases.
Status: While they recently launched an IPO roadshow, many companies in this sector keep a "dual-track" strategy, meaning they evaluate reverse mergers with shells like QNCX simultaneously with IPO plans.
3. Eikon Therapeutics
Backing: Valued at approximately $3.2 billion with significant private backing from investors like T. Rowe Price and Canada Pension Plan Investment Board.
Industry Focus: Advanced microscopy and drug discovery.
Recent Activity: They recently completed an IPO in early 2026, but were long considered a primary candidate for a major public market entry.
idk30008
prije 6 mjeseci
Can we pls see news today !!
Honestly what was the point of clearing debt and doing a 10-1 split, if this was gonna die and if we weren’t gonna stay above $1, hopefully there’s news today or tomorrow, or consider this dead
Analyst101
prije 6 mjeseci
Somethings happening behind closed doors
cianlewis
prije 6 mjeseci
RS completed
the halt is over, let's push
Cl1f0
prije 6 mjeseci
RS 1-for-10 if a merger is on the cards
Ive been doing a little digging and found some previous similar scenarios all available for you to look the Internet. Because Its blown my mind how $5.5m has been paid if they expect to go bankrupt.
Therefore i think there is something in the pipeline. Everything is strictly private and no info to be given.
So asking AI to find me similar scenarios
1. MDGL 2. IRON 3. TECX 4.LH 5. BKNG
The first 3 have similar failed drug trail and then were merged after RS as a shell and not failed company, they are all above $30.72 and MDGL is $527.
I believe we have potential to be sitting pretty here. Im not selling and if it stays above $1 then we look like were have a good start. Pretty sure it has to hold for an actual handshake but this could be one of them gems. Fingers crossed. And for all you holding im with you. NFA
Na ovoj se stranici možda nalazi sadržaj koji je izradila zajednica za koji platforma Trading 212 nije odgovorna. Uvijek sami provjerite sve informacije. Trading 212 pruža samo uslugu izvršenja i ne nudi investicijske savjete ili upravljanje portfeljem.
Izgradnja bogatstva je navika. Automatiziraj je pomoću pie.
Uloži u gotove pies ili stvori vlastite odabirom među tisućama dionica i ETF-ova
Saznaj više
Saznaj više
Pogledaj video
Kupi čak i najskuplje dionice kao što su Google, Amazon i Apple
Pogledaj video
Euronext Pariz
NYSE, NASDAQ
Xetra, Gettex
Euronext Amsterdam
Bolsa de Madrid
Wiener Börse
Londonska burza
Euronext Lisabon
Euronext Pariz
NYSE, NASDAQ
Xetra, Gettex
Euronext Amsterdam
Bolsa de Madrid
Wiener Börse
Londonska burza
Euronext Lisabon
Prikaži sve instrumente trgovanja
Podrška 24/7
Prosječno vrijeme odgovora iznosi 29 sekundi
Počni graditi svoje bogatstvo sada
Pridruži se zajednici od 5 milijuna korisnika
Preuzmi aplikaciju
Otvori račun
Preuzmi mobilnu aplikaciju
Svi prikazani statistički podaci su globalni. Broj klijenata predstavlja financirane račune.
Izvrsno
Ocjena 4,6 / 5 na osnovi 106.437 recenzije/a s platforme
Trustpilot
Ocjena 4,6 / 5 na osnovi 106.437 recenzije/a s platforme
Trustpilot
Pozvan
Excellent
Using Trading 212 has been a very productive and satisfying experience for me. Because the platform is user-friendly, dependable, and simple to navigate, investing is made to be a straightforward and convenient process. I am especially grateful for the user-friendly interface, the useful investment tools, and the capability to track the performance of my portfolio in real time.
Pozvan
I have had a fantastic experience with…
have had a fantastic experience with Trading 212. The app is modern, intuitive and incredibly easy to use, making investing feel accessible and straightforward. I particularly appreciate the clear layout, real-time updates and the ability to manage my investments conveniently in one place. The overall experience is smooth, efficient and user-friendly. Whether you are new to investing or more experienced, Trading 212 is an excellent platform that I would happily recommend to others. A brilliant app that makes investing simple!
Pozvan
Easy to use and fantastic features
Easy to use and fantastic features
Pozvan
Easy to operate app for everyone!
Easy to operate app for everyone!
Pozvan
Good platform for all my investments in…
Good platform for all my investments in one place. I have ISA and recently transferred my SIPP. I have a general investment account link to 121 debit card.
Pozvan
Awesome service and app
Awesome service and app. Well done guys :)
Pozvan
Everything is just so easy to use
Everything is just so easy to use. You can see at a glance how everything is doing.
Pozvan
Just a great platform user friendly 0…
Just a great platform user friendly 0 commissions with the pie attachment whats not to like choosing 212 compared to other platforms is literally a no brainer
Pozvan
Great app easy to move money in/out…
Great app easy to move money in and out. Good to see how much interest you are making.
Pozvan
Easy to use and intuitive
Easy to use and great dashboard to see what’s going on. Moved my stocks and shares ISA from Barclays and not looked back.
Pozvan
Easy to use app
Easy to use app, simple processes, good rate of return and regular updates on interest earned.
Pozvan
Quick and easy
I found that it was quick and easy to open an account; transfer funds in and out, best of all, to sit back and watch the monies increase.
I would recommend Trading 212
Pozvan
App is easy to use
The savings product i have has a good rate of return and I get daily updates. App is really easy to use
Pozvan
212 has been a good discovery 6 years ago
212 has been a good discovery. Excellent platform for investment, secure and user friendly. Very good interest rate and good ISA
Pozvan
Love it
Love it. Simple for a complete beginner to navigate. Perfect!
Pozvan
The best app around
The best app around, so easy to use and navigate… makes investing easy.
Pozvan
Easy access to transfer money.
Easy access to transfer money.
Daily updates regarding interest.
Pozvan
Great platform
Great platform, easy to navigate and buy/sell. Good statements are available.
Pozvan
Trading 212 is very transparent
Trading 212 is very transparent, open and clear with their activities. No outrageous deductions or charges. I recommend it for everyone interested in investment
Pozvan
Good and efficient
Good and easy to use with lots of products and investment options
Prikazuju se neke od pozitivnih recenzija naših klijenata
Naše nagrade
Česta pitanja
Koja je cijena dionice IRulya Therapeutics?
Trenutna cijena IRulya Therapeutics je 33,08 $.
Koji je 52-tjedni maksimum za IRulya Therapeutics?
52-tjedni maksimum za IRulya Therapeutics je 908 $.
Koji je 52-tjedni minimum za IRulya Therapeutics?
52-tjedni minimum za IRulya Therapeutics je 15,1 $.
Kakva je tjedna učinkovitost IRulya Therapeutics?
U proteklom tjednu cijena IRulya Therapeutics promijenila se za 3,28 %.
Kakva je mjesečna učinkovitost IRulya Therapeutics?
Tijekom proteklog mjeseca, cijena IRulya Therapeutics promijenila se za 5,52 %.
Kakva je 3-mjesečna performansa IRulya Therapeutics?
U posljednja tri mjeseca cijena IRulya Therapeutics promijenila se za 78,43 %.
Kakva je 6-mjesečna performansa IRulya Therapeutics?
U posljednjih šest mjeseci cijena IRulya Therapeutics promijenila se za 20,73 %.
Kakva je godišnja učinkovitost IRulya Therapeutics?
Tijekom protekle godine cijena IRulya Therapeutics promijenila se za −90,91 %.